These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28592989)

  • 1. Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.
    Silas OA; Achenbach CJ; Hou L; Murphy RL; Egesie JO; Sagay SA; Agbaji OO; Agaba PE; Musa J; Manasseh AN; Jatau ED; Dauda AM; Akanbi MO; Mandong BM
    Infect Agent Cancer; 2017; 12():34. PubMed ID: 28592989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Mortality From a Population-Based Cancer Registry Data in Jos, Nigeria: A Resource-Limited Setting.
    Silas OA; Musa J; Afolaranmi TO; Sagay AS; Evans CT; Achenbach CJ; Hou L; Murphy RL
    Front Med (Lausanne); 2020; 7():227. PubMed ID: 32582731
    [No Abstract]   [Full Text] [Related]  

  • 3. Cervical cancer survival in a resource-limited setting-North Central Nigeria.
    Musa J; Nankat J; Achenbach CJ; Shambe IH; Taiwo BO; Mandong B; Daru PH; Murphy RL; Sagay AS
    Infect Agent Cancer; 2016; 11():15. PubMed ID: 27014366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria.
    Agbaji OO; Abah IO; Falang KD; Ebonyi AO; Musa J; Ugoagwu P; Agaba PA; Sagay AS; Jolayemi T; Okonkwo P; Idoko JA; Kanki PJ
    Curr HIV Res; 2015; 13(3):184-92. PubMed ID: 25986369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, Nigeria.
    Ebonyi AO; Oguche S; Meloni ST; Sagay SA; Kyriacou DN; Achenbach CJ; Agbaji OO; Oyebode TA; Okonkwo P; Idoko JA; Kanki PJ
    J AIDS Clin Res; 2014; 5(12):. PubMed ID: 30416842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality among pulmonary tuberculosis and HIV-1 co-infected Nigerian children being treated for pulmonary tuberculosis and on antiretroviral therapy: a retrospective cohort study.
    Ebonyi AO; Oguche S; Agbaji OO; Sagay AS; Okonkwo PI; Idoko JA; Kanki PJ
    Germs; 2016 Dec; 6(4):139-150. PubMed ID: 28053917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
    Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
    Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.
    Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA
    PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of AIDS and non-AIDS related mortality among people living with HIV in Shiraz, southern Iran: a 20-year retrospective follow-up study.
    Gheibi Z; Shayan Z; Joulaei H; Fararouei M; Beheshti S; Shokoohi M
    BMC Infect Dis; 2019 Dec; 19(1):1094. PubMed ID: 31888541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study.
    Adamu AL; Gadanya MA; Abubakar IS; Jibo AM; Bello MM; Gajida AU; Babashani MM; Abubakar I
    BMC Infect Dis; 2017 Feb; 17(1):170. PubMed ID: 28231851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and risk factors for pulmonary tuberculosis among newly diagnosed HIV-1 infected Nigerian children.
    Ebonyi AO; Oguche S; Ejeliogu EU; Agbaji OO; Shehu NY; Abah IO; Sagay AS; Ugoagwu PO; Okonkwo PI; Idoko JA; Kanki PJ
    Germs; 2016 Mar; 6(1):21-8. PubMed ID: 27019829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation and survival in patients with hematologic malignancies in Jos, Nigeria: A retrospective cohort analysis.
    Egesie OJ; Agaba PA; Silas OA; Achenbach C; Zoakah A; Agbaji OO; Madaki JA; Okeke EN; Hou L; Sagay AS; Murphy R
    J Med Trop; 2018; 20(1):49-56. PubMed ID: 29963503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of HIV-1 screening and anti-retroviral treatment programs in a resource-poor setting: results from a faith-based organization in Jos, Plateau State, Nigeria.
    Lum H; Isichei C; Isichei-Wakili M; Redfield R
    Afr Health Sci; 2007 Jun; 7(2):93-100. PubMed ID: 17594286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with antiretroviral treatment interruption in human immunodeficiency virus (HIV)-1-infected children attending the Jos University Teaching Hospital, Jos, Nigeria.
    Ebonyi AO; Ejeliogu EU; Okpe SE; Shwe DD; Yiltok ES; Ochoga MO; Oguche S
    Niger Med J; 2015; 56(1):43-7. PubMed ID: 25657493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia region, Ethiopia: a retrospective cohort study.
    Tesfamariam K; Baraki N; Kedir H
    BMC Res Notes; 2016 Dec; 9(1):512. PubMed ID: 27998310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
    Croxford S; Kitching A; Desai S; Kall M; Edelstein M; Skingsley A; Burns F; Copas A; Brown AE; Sullivan AK; Delpech V
    Lancet Public Health; 2017 Jan; 2(1):e35-e46. PubMed ID: 29249478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.